H
Harald Darius
Researcher at University of Mainz
Publications - 221
Citations - 21628
Harald Darius is an academic researcher from University of Mainz. The author has contributed to research in topics: Myocardial infarction & Atrial fibrillation. The author has an hindex of 49, co-authored 213 publications receiving 19858 citations. Previous affiliations of Harald Darius include Thomas Jefferson University & Durham University.
Papers
More filters
Journal ArticleDOI
Dabigatran versus warfarin in patients with atrial fibrillation
Stuart J. Connolly,Michael D. Ezekowitz,John W. Eikelboom,Jonas Oldgren,Amit Parekh,Janice Pogue,Paul A. Reilly,Ellison Themeles,Jeanne Varrone,Susan Wang,Marco Alings,Denis Xavier,Jun Zhu,Rafael Diaz,Basil S. Lewis,Harald Darius,Hans-Christoph Diener,Campbell D. Joyner,Lars Wallentin +18 more
TL;DR: In patients with atrial fibrillation, dabigatran given at a dose of 110 mg was associated with rates of stroke and systemic embolism that were similar to those associated with warfarin, as well as lower rates of major hemorrhage.
Journal ArticleDOI
Bivalirudin for Patients with Acute Coronary Syndromes
Gregg W. Stone,Brent T. McLaurin,David A. Cox,Michel E. Bertrand,A. Michael Lincoff,Jeffrey W. Moses,Harvey D. White,Stuart J. Pocock,James H. Ware,Frederick Feit,Antonio Colombo,Philip E. Aylward,Angel Cequier,Harald Darius,Walter Desmet,Ramin Ebrahimi,Martial Hamon,Lars Hvilsted Rasmussen,Hans J. Rupprecht,James W. Hoekstra,Roxana Mehran,E. Magnus Ohman +21 more
TL;DR: In patients with moderate- or high-risk acute coronary syndromes who were undergoing invasive treatment with glycoprotein IIb/IIIa inhibitors, bivalirudin was associated with rates of ischemia and bleeding that were similar to those with heparin.
Journal ArticleDOI
Apixaban with Antiplatelet Therapy after Acute Coronary Syndrome
John H. Alexander,Renato D. Lopes,Stefan James,Rakhi Kilaru,Yaohua He,Puneet Mohan,Deepak L. Bhatt,Shaun G. Goodman,Freek W.A. Verheugt,Marcus Flather,Kurt Huber,Danny Liaw,Steen Elkjær Husted,Jose Lopez-Sendon,Raffaele De Caterina,Petr Jansky,Harald Darius,Dragos Vinereanu,Jan H. Cornel,Frank Cools,Dan Atar,Jose L. Leiva-Pons,Matyas Keltai,Hisao Ogawa,Prem Pais,Alexander Parkhomenko,Witold Rużyłło,Rafael Diaz,Harvey D. White,Mikhail Ruda,Margarida Geraldes,Jack Lawrence,Robert A. Harrington,Lars Wallentin +33 more
TL;DR: The addition of apixaban, at a dose of 5 mg twice daily, to antiplatelet therapy in high-risk patients after an acute coronary syndrome increased the number of major bleeding events without a significant reduction in recurrent ischemic events as mentioned in this paper.
Journal ArticleDOI
Antithrombotic Therapy after Acute Coronary Syndrome or PCI in Atrial Fibrillation
Renato D. Lopes,Gretchen M. Heizer,Ronald Aronson,Amit N. Vora,Tyler Massaro,R Mehran,Shaun G. Goodman,Shaun G. Goodman,Stephan Windecker,Harald Darius,J. Li,Oleg Averkov,Maria Cecilia Bahit,Otavio Berwanger,Andrzej Budaj,Ziad Hijazi,Alexander Parkhomenko,Peter Sinnaeve,Robert F. Storey,Holger Thiele,Dragos Vinereanu,Christopher B. Granger,John H. Alexander,Augustus Investigators +23 more
TL;DR: In patients with atrial fibrillation and a recent acute coronary syndrome or PCI treated with a P2Y12 inhibitor, an antithrombotic regimen that included apixaban, without aspirin, resulted in less bleeding and fewer hospitalizations without significant differences in the incidence of ischemic events than regimens that included a vitamin K antagonist, aspirin, or both.
Journal ArticleDOI
High prevalence of peripheral arterial disease and co-morbidity in 6880 primary care patients: cross-sectional study.
Curt Diehm,Alexander Schuster,Jens R. Allenberg,Harald Darius,Roman L. Haberl,Stefan Lange,David Pittrow,Berndt von Stritzky,Gerhart Tepohl,Hans-Joachim Trampisch +9 more
TL;DR: Doppler ultrasound measurement for ABI determinations is a non-invasive, inexpensive, reliable tool in primary care and enables GPs to identify patients at risk of PAD, particularly with regard to other manifestations of atherothrombosis.